344405-51-2Relevant articles and documents
FERROPTOSIS INHIBITORS–DIARYLAMINE PARA-ACETAMIDES
-
Paragraph 01142; 01144; 01158; 01160, (2021/09/11)
Provided are compounds that inhibit ferroptosis activity, or modulate or inhibit a disease associated with ferroptosis dysregulation, such as neuropathy, ischemia reperfusion injury, acute kidney failure and cancer, including corresponding sulfonamides, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition, and detecting a resultant improvement in the person's health or condition.
Compositions for dyeing keratinic fibres, containing paraphenylenediamine derivatives with an azetidinyl group
-
, (2008/06/13)
The invention relates to novel compositions for the oxidation dyeing of keratin fibers, comprising at least one para-phenylenediamine derivative containing an azetidinyl group as oxidation base, to the dyeing process and to the dyeing kit using this composition, and also to novel para-phenylenediamines containing an azetidinyl group.